Table ronde sur la thérapie par la lumière rouge : Comment les longueurs d’onde de 660 nm et 850 nm favorisent la cicatrisation des tissus

A red light therapy panel uses two wavelength ranges that reach different tissue depths. Red light at 660nm penetrates roughly 8-10mm, reaching the epidermis, dermis, and superficial subcutaneous tissue, where it stimulates dermal fibroblasts and collagen production. Near-infrared at 850nm penetrates 15-30mm or more, reaching muscle, fascia, joint capsules, and bone surface for deeper recovery work. Both wavelengths are absorbed by cytochrome c oxidase, the enzyme in Complex IV of the mitochondrial electron transport chain, which displaces inhibitory nitric oxide and increases ATP production by roughly 30-50% per fluorescent ATP sensor studies. This is photobiomodulation: a non-thermal, photochemical process, not heat therapy. Vacuactivus builds red light therapy equipment for wellness centers, so here is the mechanism explained precisely rather than dressed up as marketing.

The ‘red light therapy panel’ search category drives 12,100 monthly US searches per Serpstat 2026 data, alongside ‘red light panel’ at 14,800/mo and ‘red light therapy equipment’ at 4,400/mo – almost all with informational intent from users trying to understand what wavelengths actually do before purchasing. This guide covers exactly that: what nm means for tissue depth, what 660nm reaches in the skin, what 850nm reaches in deep tissue, how cytochrome c oxidase converts photons into ATP, why photobiomodulation is not infrared sauna heat, how dose math works (irradiance × time = J/cm² delivered), and two honest controversies in the industry – the multi-wavelength debate and the irradiance measurement question. The wavelength science determines everything else about how a red light panel actually works.

Vacuactivus manufactures red light therapy equipment including panels and the InfraCouch Red Light commercial bed (630-660nm plus 810-850nm) for medspas, recovery studios, and wellness centers. This educational article does not position red light therapy as a cure for any diagnosed condition – red light panels are wellness devices for general wellness support, not medical treatment for arthritis, chronic pain, or aging reversal. The dose response is also biphasic (too little does nothing, and excessive exposure can reduce benefit), and clinical research on wavelengths outside the well-supported 660nm and 850nm bands remains thinner than the core pair. The precise wavelength mechanism covered below is what a wellness center operator or informed home user actually needs to know before evaluating any red light therapy panel purchase decision.

What the Numbers Mean: nm, Wavelength, and Tissue Depth

The nm stands for nanometers, a measurement of the wavelength of light. Different wavelengths correspond to different colors of light and, more importantly, different penetration depths and different biological effects in tissue. Red light therapy operates in what researchers call the optical window of biological tissue: roughly 620 to 1400nm, the range where light can penetrate deep enough to have a biological effect rather than being absorbed at the surface or scattered away. Below that window (in the blue and green range), light stops at the skin. Above it (deeper into infrared), water molecules in tissue absorb the energy as heat rather than triggering the specific photochemical reaction that makes red light therapy work. Within the optical window, two ranges carry almost all the clinical research: visible red at 630-680nm and near-infrared at 810-850nm.

A red light therapy panel that lists 660nm and 850nm is targeting the two best-supported points in that optical window. The wavelength determines depth, and depth determines which specific tissue the light can actually reach at therapeutic irradiance. Related red light wavelengths follow the same physics: shorter red wavelengths like 630nm stay shallower than 660nm, and NIR panel wavelengths at 810nm and 830nm reach depths similar to 850nm. Deeper red light wavelengths in the NIR range like 940nm and 1072nm push further but with less clinical research supporting specific applications. Understanding these red light wavelengths matters because a claim like ‘reaches deep muscle’ only makes physical sense at 810-850nm or deeper – a 660nm-only panel does not reach the joint under the skin regardless of how it is marketed. This is why any NIR panel or near-infrared panel targeting deep tissue must include 850nm or an equivalent NIR panel wavelength alongside the 660nm surface treatment. A dual wavelength panel combining 660nm and 850nm covers both depth ranges in a single session, which is why dual wavelength design has become the standard configuration. When comparing red light wavelengths across a NIR panel or near-infrared panel product line, the wavelength count and wavelength selection matter more than marketing terminology, and a proper dual wavelength design at adequate irradiance beats a broader red light wavelengths spread at low irradiance per band. Any near-infrared panel with dual wavelength support (660nm + 850nm) covers the two best-researched red light wavelengths in the optical window.

660nm: What Red Light Does at 8-10mm

Light at 660nm falls in the visible red spectrum. It is the deep red glow you see when a red light therapy panel switches on. This wavelength penetrates approximately 8-10mm, reaching the epidermis, dermis, and superficial subcutaneous tissue per RedLightOS April 2026 and The Light Therapy Institute 2026 penetration data. At that depth, 660nm light interacts primarily with dermal fibroblasts – the cells responsible for producing collagen and elastin, the structural proteins that keep skin firm and elastic. Red and near-infrared exposure upregulates collagen and elastin synthesis in dermal fibroblasts per Superpower June 2026 evidence guide summarizing the mechanism. This is the cellular basis for the anti-aging applications of red light therapy panels.

Clinical support for 660nm specifically: the Wunsch and Matuschka 2014 peer-reviewed study found subjects treated with wavelengths in the 611-650nm range showed significant improvements in skin measures over a treatment course. Within the broader red range, 660nm consistently outperforms 630nm for anti-aging outcomes in clinical studies per The Light Therapy Institute 2026, which is why 660nm has emerged as the standard red wavelength point in dual-wavelength panels. The 2025 LED mask randomized controlled trial referenced by Mito Red Light using 630nm plus 850nm across 16 weeks documented crow’s-feet reduction, supporting the broader wavelength combination rather than 660nm in isolation. Primary applications for the 660nm portion of a red light therapy panel: skin health, collagen support, complexion work and wrinkle applications, surface wound healing, and hair follicle stimulation at the scalp (where the target sits within the 8-10mm reach of 660nm red wavelengths). For anything deeper, 660nm alone is insufficient.

850nm: What Near-Infrared Does at 15-30mm

Light at 850nm sits in the near-infrared range and is nearly invisible to the eye – a red light therapy panel with 850nm LEDs may look like it is ‘off’ compared to the visible 660nm glow, but the NIR emitters are working. This wavelength penetrates the deepest of the commonly available red light therapy wavelengths, reaching 15-30mm or more per The Light Therapy Institute 2026 penetration data, which puts it into deep muscle, fascia, joint capsules, and bone surface. It is absorbed by cytochrome c oxidase in these deeper tissues, plus the water and protein content within cells at those depths, triggering the same photobiomodulation cascade at tissue that visible red wavelengths simply cannot reach in therapeutically meaningful quantities. This is the practical reason a good red light therapy panel needs both wavelengths: treating a sore knee with 660nm alone means treating the skin above the knee, not the joint itself.

Primary applications for the 850nm near-infrared portion of a red light therapy panel: joint pain and arthritis management support (wellness use, not medical treatment), deep muscle recovery and athletic performance context, connective tissue repair, circulation improvement, and systemic anti-inflammatory effects per Superpower June 2026 evidence framework. 850nm is the most widely used near-infrared wavelength in both consumer and commercial red light therapy panels per Mito Red Light May 2026 wavelength authority guide. Related NIR wavelengths (810nm, 830nm) fall within the same therapeutic window and produce comparable positive results in clinical studies, so the practical difference between them is meaningful but not dramatic. Some panels combine 810nm plus 850nm to broaden NIR coverage, while dual-wavelength purists argue for concentrating power in 660nm plus 850nm alone (discussed further in the multi-wavelength debate section below).

The Mechanism: How Cytochrome c Oxidase Turns Light Into ATP

Photobiomodulation works through a specific enzyme, not through heat. Cytochrome c oxidase (CCO) is a copper-containing enzyme in Complex IV of the mitochondrial electron transport chain, and it is the primary photoacceptor for red and near-infrared light in tissue per Superpower June 2026 evidence guide and Hamblin 2017 Harvard Medical School photobiomodulation review. The mechanism runs in four sequential steps. Step 1: photons at 630-850nm strike the CCO enzyme in mitochondrial Complex IV and are absorbed by the copper centers. Step 2: that absorption displaces inhibitory nitric oxide bound to the CCO enzyme, removing a brake on cellular respiration that had been slowing mitochondrial ATP output. Step 3: with the nitric oxide brake released, ATP production increases – studies using fluorescent ATP sensors document increases of roughly 30-50% in cellular ATP following appropriate red light or near-infrared exposure at therapeutic irradiance per Peak Primal Wellness March 2026 review of the ATP quantification research.

Step 4: downstream effects follow the ATP increase. The nitric oxide released from CCO drives vasodilation (widening blood vessels) and improved local circulation, delivering more oxygen and nutrients to the treated tissue. Modulation of reactive oxygen species (ROS) inside the mitochondria triggers anti-inflammatory signaling cascades. Dermal fibroblasts upregulate collagen and elastin synthesis in surface tissue exposed to 660nm. Michael Hamblin of Harvard Medical School confirmed in his 2017 peer-reviewed review that photobiomodulation has a positive effect on tissue regeneration, inflammation reduction, and collagen support when the correct wavelengths and dosing are applied. Additional peer-reviewed support: Shinhmar et al. 2020 at UCL Institute of Ophthalmology (Jeffery lab) documented that brief 670nm exposure improves mitochondrial function in the retina of older adults – a specific in vivo human tissue demonstration of the photobiomodulation effect. This cytochrome c oxidase mechanism is among the better-characterized in the consumer-device space, with consistent findings across cell-line and human tissue studies.

Why a Red Light Panel Is Not an Infrared Sauna

Red light therapy panels get confused with three other technologies, and the mechanism distinction matters for what to expect from each device category. Infrared saunas work through heat: far-infrared wavelengths agitate water molecules in tissue to raise tissue temperature, driving cardiovascular response and sweating. Photobiomodulation is non-thermal – a photochemical reaction where specific red and NIR photons are absorbed by a specific enzyme (cytochrome c oxidase), triggering the CCO cascade described above rather than heating tissue. A red light therapy panel warms the skin only slightly at most during a session, well below infrared sauna temperatures. Medical LLLT lasers (low-level laser therapy) use the same wavelength science as red light panels but with different power density and beam optics in clinical settings for targeted treatment – the underlying wavelength physics is identical, but the delivery format differs. Near-infrared belts and wraps use the same wavelengths at lower irradiance in a narrower form factor for portability.

Heat lamps produce infrared-B and infrared-C wavelengths that generate thermal energy without the CCO photochemistry, which means heat lamps deliver warmth and comfort but not the cellular ATP effect of a red light therapy panel. The distinguishing feature of photobiomodulation is the specific absorption of red and near-infrared photons in the 620-1400nm optical window by cytochrome c oxidase in the mitochondria, per Superpower June 2026 evidence framework. You are not warming the tissue when you use a red light therapy panel – you are delivering photons that a specific mitochondrial enzyme absorbs to modulate cellular respiration. This is why session times are 10-15 minutes at close range rather than the 30-45 minutes at heat-driven sweating temperature that characterize infrared saunas. Same broad wavelength family (infrared spectrum), completely different biological mechanism and completely different session protocol.

Dose Math: Irradiance, Distance, and Session Time

Wavelength determines where the light goes; irradiance and session time determine how much arrives at target tissue. Irradiance (also called power density) is measured in mW/cm² at a stated treatment distance from the panel surface. Research protocols generally require 50-150 mW/cm² at treatment distance to deliver sufficient photons to activate cytochrome c oxidase per Peak Primal Wellness March 2026 review of PBM irradiance research. Multiply irradiance by session time to get the delivered dose in J/cm², which is the number that actually determines biological outcome. This is where red light therapy panels differ most in practice: an underpowered panel at the correct 660nm or 850nm wavelengths still requires impractically long sessions to reach a useful J/cm² dose. Distance matters because irradiance falls off sharply with distance from the panel – for most panels and masks, 1-6 inches from the skin is the working range. Typical protocol: 10-15 minute sessions, 3-5 times per week, with results generally appearing after 4-6 weeks of consistent use per manufacturer protocols across the industry.

One honest caveat on published irradiance specifications: irradiance figures are measured differently across the industry, which affects how comparable spec-sheet numbers really are. A spectroradiometer measures only the wavelengths the panel actually emits (typically 660nm and 850nm), giving a true reading of therapeutic light reaching the target per Mito Red Light June 2026 irradiance methodology coverage with Dr. Alexis Cowan PhD (Princeton) commentary. A solar meter registers broadband energy including wavelengths that never reach the target tissue therapeutically, which inflates the number reported on a spec sheet. Always ask any red light therapy panel manufacturer for the measurement method (spectroradiometer versus solar meter) and the stated treatment distance – without both pieces of information, an irradiance number by itself tells you very little about actual delivered dose. Third-party lab testing with methodology disclosure is the industry-standard verification approach for irradiance claims. This transparency question is one of two honest controversies in the red light therapy panel industry, discussed alongside the multi-wavelength debate in the next section.

Are More Wavelengths Better? The Multi-Wavelength Debate

The multi-wavelength debate honestly. Some red light therapy panels market three, five, or seven distinct wavelengths as a premium feature over the standard 660nm plus 850nm dual-wavelength design. The argument for multi-wavelength: each additional wavelength can address a distinct penetration depth or specific tissue target, and some clinical work supports 630nm and 810nm and 830nm alongside the core 660nm plus 850nm pair per Mito Red Light 2026 wavelength authority guide. The counterargument against multi-wavelength (the dual-wavelength purist position): published clinical research on wavelengths outside 660nm and 850nm is significantly thinner than on the core pair, and total panel power gets divided across all emitters, so each individual wavelength delivers lower irradiance than it would in a focused dual-wavelength design where power is concentrated in the two best-supported bands. Both arguments have technical merit.

The practical position for most red light therapy panel buyers: 660nm + 850nm remains the most common and best-supported combination available in 2026. A well-built dual-wavelength panel operating at adequate irradiance (50-150 mW/cm² measured with a spectroradiometer at stated distance) generally outperforms a multi-wavelength panel that spreads thin power across bands with limited clinical evidence per Mito Red Light 2026 practical guidance. If a panel does offer more than two wavelengths, verify that irradiance per band still lands in the useful range rather than treating wavelength count as an automatic quality signal. This is where the earlier irradiance measurement question matters most: a multi-wavelength panel claiming high overall irradiance measured with a solar meter may deliver very little therapeutic light per band once the number is decomposed by wavelength. The wavelength count on a panel spec sheet only translates to biological effect when each wavelength meets the 50-150 mW/cm² threshold at treatment distance.

Panels vs Full-Body Systems for Wellness Centers

Brief B2B context, since the primary intent of this article is informational science explanation. The same 660nm and 850nm wavelength science applies whether the delivery format is a red light therapy panel, a bed, or a full-body pod. What changes across formats is coverage area and throughput per session. A red light therapy panel targets one body region at a time and suits home users, targeted treatment for specific muscle or skin regions, and clinics adding light therapy as a supplemental service to an existing menu. A full-body bed or pod wraps 660nm and 850nm around the entire body simultaneously in a single 10-20 minute session, which matters practically when a wellness center runs 20-30 clients per day and cannot spend that time repositioning a single panel between body regions per client. Commercial systems also use higher-output LEDs and construction tolerances rated for continuous daily operation, with LED lifespans typically 50,000-100,000 hours in commercial-grade equipment.

Vacuactivus manufactures red light therapy equipment including panels and the InfraCouch commercial bed  with 630-660nm plus 810-850nm wavelengths for medspas, recovery studios, and wellness centers. The wavelength physics covered throughout this article is identical whether delivered as a red light therapy panel or a full-body InfraCouch commercial bed – the engineering around throughput and continuous-use durability is what practically separates the delivery formats for commercial buyers. For biohackers and longevity-focused users evaluating multi-modality integration, the HaloX longevity capsule biohacking pod combines red light therapy with other longevity modalities in a single pod format. Commercial buyers evaluating red light therapy equipment options should verify irradiance measurement methodology, LED lifespan ratings, wavelength configuration (dual versus multi), and continuous-use build rating before purchase per the same criteria discussed throughout this article for any red light panel evaluation.

Foire aux questions

Q1. What is the difference between 660nm and 850nm red light?

The difference is penetration depth and which tissue the light reaches. 660nm is visible red light that penetrates roughly 8-10mm, reaching the epidermis, dermis, and superficial subcutaneous tissue, where it stimulates dermal fibroblasts and collagen production. 850nm is near-infrared, nearly invisible to the eye, and penetrates 15-30mm or more into deep muscle, fascia, joint capsules, and bone surface. Both wavelengths are absorbed by the same enzyme (cytochrome c oxidase in Complex IV of the mitochondrial electron transport chain) and trigger the same cellular pathway, but they reach different tissue depths. This is why red light therapy panels combine both: 660nm handles skin and collagen work at 8-10mm, 850nm handles deeper muscle and joint recovery at 15-30mm+. Treating a sore knee with 660nm alone means treating the skin above the knee rather than the joint itself.

Q2. How deep does red light therapy penetrate?

Penetration depth depends on wavelength. Red light at 660nm penetrates approximately 8-10mm, reaching the epidermis, dermis, and superficial subcutaneous tissue per RedLightOS 2026 penetration data. Near-infrared at 850nm penetrates 15-30mm or more, reaching deep muscle, fascia, joint capsules, and bone surface per The Light Therapy Institute 2026 data. Related wavelengths follow the same pattern: shorter red wavelengths like 630nm stay shallower than 660nm, while NIR wavelengths at 810nm and 830nm fall in a similar deep-tissue range to 850nm. All of these red light wavelengths sit inside what researchers call the optical window of biological tissue, roughly 620-1400nm, where light can penetrate meaningfully rather than stopping at the surface or being absorbed as heat. Actual delivered depth also depends on irradiance and distance from the panel, since an underpowered panel delivers fewer photons to any depth.

Q3. How does red light therapy work at the cellular level?

Red light therapy works through photobiomodulation, a non-thermal photochemical process. Photons at 630-850nm are absorbed by cytochrome c oxidase, a copper-containing enzyme in Complex IV of the mitochondrial electron transport chain and the primary photoacceptor for these red light wavelengths. That absorption displaces inhibitory nitric oxide bound to the enzyme, which removes a brake on cellular respiration. ATP production then increases: studies using fluorescent ATP sensors document increases of roughly 30-50% in cellular ATP after appropriate exposure per Peak Primal Wellness 2026 review of the research. Downstream, the released nitric oxide drives vasodilation and improved circulation, reactive oxygen species modulation triggers anti-inflammatory signaling, and dermal fibroblasts upregulate collagen and elastin synthesis in surface tissue. Michael Hamblin of Harvard Medical School documented this photobiomodulation mechanism in his 2017 peer-reviewed anti-inflammatory review.

Q4. Is red light therapy the same as an infrared sauna?

No. An infrared sauna works through heat: far-infrared wavelengths agitate water molecules in tissue to raise tissue temperature, driving cardiovascular response and sweating. Red light therapy is photobiomodulation, a non-thermal photochemical reaction where specific red and near-infrared photons (660nm plus 850nm) are absorbed by cytochrome c oxidase in the mitochondria to trigger the CCO cascade. A red light therapy panel warms the skin slightly at most during a session, well below infrared sauna temperatures. The distinction matters because the biological effects come from completely different sources: the sauna delivers thermal stress, the red light therapy panel delivers photons to a specific enzyme. Red light panels are also different from medical LLLT lasers (same wavelength science but different power density and beam optics in clinical settings) and from heat lamps (which emit infrared-B and infrared-C for thermal energy without the CCO photochemistry).

Q5. Are more wavelengths better in a red light panel?

Not necessarily. Some red light therapy panels market three, five, or seven wavelengths as a premium feature, and the multi-wavelength argument has some merit: each additional wavelength can address a distinct penetration depth or tissue target. The counterargument is that published clinical research on wavelengths outside 660nm and 850nm is significantly thinner than on the core pair, and total panel power gets divided across all emitters, so each wavelength delivers lower irradiance than it would in a focused dual-wavelength design. The practical position: 660nm + 850nm remains the most common and best-supported combination in 2026 red light panels. A well-built dual-wavelength panel operating at adequate irradiance (50-150 mW/cm²) outperforms a multi-wavelength panel spreading thin power across bands with limited evidence. If a red light therapy panel offers more wavelengths, verify irradiance per band still lands in a useful range rather than treating wavelength count as an automatic quality signal.

Q6. What irradiance do you need for red light therapy to work?

Research protocols generally require 50-150 mW/cm² at the treatment distance to deliver enough photons to activate cytochrome c oxidase per Peak Primal Wellness 2026 review. Irradiance (power density) multiplied by session time gives the delivered dose in J/cm², which is the number that actually determines biological outcome. This is where red light therapy panels differ most in practice: an underpowered panel at the correct 660nm or 850nm wavelengths still requires impractically long sessions to reach a useful J/cm² dose. One important caveat on published irradiance specs: irradiance figures are measured differently across the industry. A spectroradiometer measures only the specific wavelengths the panel actually emits (giving true therapeutic light reaching target), while a solar meter registers broadband energy that never reaches target tissue therapeutically, which inflates the reported number per Mito Red Light 2026 with Dr. Alexis Cowan PhD (Princeton) commentary. Always ask for the measurement method and stated distance – without both, an irradiance number tells you very little.

Q7. How long and how often should you use a red light therapy panel?

The typical red light therapy panel protocol is 10-15 minute sessions, 3-5 times per week, with visible results generally appearing after 4-6 weeks of consistent use. Distance matters because irradiance drops sharply as you move away from the panel: for most red light therapy panels and masks, 1-6 inches from the skin is the working treatment range. Session length should be calculated from your specific device’s actual irradiance rather than copied from a generic recommendation – at 50-150 mW/cm², 10-15 minutes delivers a useful J/cm² dose, but a weaker red light panel needs longer to reach the same J/cm² dose. More is not automatically better: photobiomodulation follows a biphasic dose response, meaning too little exposure does nothing biologically useful and excessive exposure can actually reduce the benefit. Consistency of sessions over weeks matters more than long individual sessions.

Q8. Can you use 660nm and 850nm at the same time?

Yes, and most clinical-grade red light therapy panels are designed to run both wavelengths simultaneously. Using 660nm and 850nm together delivers a broader treatment effect because the two wavelengths reach different tissue depths in the same session: 660nm works on skin, collagen, and surface tissue at 8-10mm depth while 850nm reaches deep muscle, fascia, and joints at 15-30mm+ depth. You can also run them separately depending on treatment goal – 660nm only for skin and collagen work, 850nm only for deep tissue and joint recovery. The dual-wavelength 660nm plus 850nm protocol is what most clinical trials on combined red and near-infrared light therapy have used. Both wavelengths activate the same cytochrome c oxidase pathway in the mitochondria, so running them together does not create a photochemical conflict, it simply covers more tissue depth per session at the same treatment time.

Conclusion

A red light therapy panel uses 660nm visible red for surface skin work (8-10mm depth, dermal fibroblasts, collagen production) and 850nm near-infrared for deep tissue recovery (15-30mm+ depth, muscle, fascia, joint capsules, bone surface). Both wavelengths are absorbed by cytochrome c oxidase in Complex IV of the mitochondrial electron transport chain, displacing inhibitory nitric oxide and raising ATP production by roughly 30-50% per fluorescent ATP sensor studies. This is photobiomodulation – a non-thermal photochemical mechanism, not infrared sauna heat. Dose depends on both irradiance (50-150 mW/cm² measured with a spectroradiometer at stated distance) and session time, delivering J/cm² across 10-15 minute sessions 3-5 times per week with results at 4-6 weeks. The 660nm plus 850nm dual-wavelength combination is the best-supported configuration in current clinical research, though the multi-wavelength debate continues among manufacturers.

For B2B wellness operators considering red light therapy equipment across formats, the Best Red Light Therapy Equipment for Wellness Centers B2B Guide commercial buyer guide covers equipment selection for spas and recovery studios. For the full-body red light bed format specifically, see the Red Light Bed Therapy Commercial Tanning-Style Beds for Spas  commercial bed comparison, or the Best At-Home Red Light Therapy Why Pros Choose Pro Equipment home vs pro-grade equipment discussion. For commercial buyer decision-making, the Red Light Therapy Equipment for Sale Commercial Buying Checklist commercial buying checklist covers verification of irradiance methodology, LED lifespan, and dual-wavelength configuration for wellness center operators evaluating red light therapy equipment procurement.